biopsies were performed immediately prior to RC. A standardized bladder map diagram was used to index cystoscopic findings. The endoscopic findings and transurethral biopsy results were then compared to the final pathologic cystectomy specimen RESULTS: To date, 39 patients consented to the study, and 36 have received RC. 35 had adequate data for analysis. 22 (63%) underwent RC for MIBC, while 13 (37%) had high-risk NMIBC. 21 (60%) received NAC. On SEE, 17 (49%) patients were noted to have detectable cancer. Upon extirpation, pT0, pTis, pTa, pT1, pT2, pT3, and pT4 UC was found in 11 (31%), 7 (20%), 1 (3%), 2 (6%), 2 (6%), 6 (17%), 6 (17%), respectively. The sensitivity of SEE to predict presence of MIBC at RC was 80.0%. Negative predictive value of SEE to rule out any residual cancer at RC was 55%, and to rule out MIBC was 77.8%. Of 18 patients with no residual disease on SEE, 10 had concordant and 8 had discordant findings on final pathology. MIBC was found in 4 of the 8 discordant patients ( As an alternative to bowel urinary conduit after radical cystectomy (RC) a diversion which regenerates non-absorptive urinary tissue mucosa has been developed known as the Neo-Urinary Conduit (NUC). The NUC is produced by seeding an autologous population of adipose-sourced smooth muscle cells (SMC) onto a biodegradable PLGA scaffold. We report the outcomes of a Phase I first in human clinical trial (NCT01087697) of NUC implantation after RC.
INTRODUCTION AND OBJECTIVES:
As an alternative to bowel urinary conduit after radical cystectomy (RC) a diversion which regenerates non-absorptive urinary tissue mucosa has been developed known as the Neo-Urinary Conduit (NUC). The NUC is produced by seeding an autologous population of adipose-sourced smooth muscle cells (SMC) onto a biodegradable PLGA scaffold. We report the outcomes of a Phase I first in human clinical trial (NCT01087697) of NUC implantation after RC.
METHODS: SMC was isolated from fat, ex vivo expanded, and grown on a biodegradable PLGA scaffold. NUC implantation involved ureteral anastomosis using the Wallace technique into a scaffold lined with SMC. The NUC was wrapped with omentum or peritoneum for blood supply. Ureteral stents and a stomal catheter were left in place. Indications for NUC explantation with ileal conduit diversion were stomal stenosis or NUC stricture leading to upper urinary tract compromise.
RESULTS: Seven men and one women underwent NUC implantation with an average age of 63 years. Indication for RC was MIBC (4 out of 8) followed by high-risk NMIBC (3 out of 8) and BCG-refractory carcinoma in-situ (1 out of 8). All patients had successful NUC placement and showed evidence of early stages of urinary tissue regeneration including de novo urothelium and smooth muscle bundles as seen by trichrome and immunostaining (calponin, alpha smooth muscle actin). Histology was performed in NUCs that were explanted. The average length of stay (LOS) was 5.6 days (range: 5-8) and there were no high-grade (Clavien 3 or higher) in-hospital complications. One patient died from disease at 8 months after NUC and another died from a myocardial infarction at 6 weeks after NUC. In the remaining 6 patients, all NUCs were eventually explanted (Figure 1 ) for either stomal stenosis (3 out of 6) or NUC stricture (3 out of 6). The average NUC lifespan was 250 days (range: 42-484) .
CONCLUSIONS: This Phase I clinical trial showed successful NUC implantation with development of viable urinary tissue. All patients did well during initial hospitalization with no major complications. Ultimately, NUC explantation was indicated in all patients due to stomal stenosis or NUC stricture. Future studies should focus on implantation techniques to prevent stricture formation. INTRODUCTION AND OBJECTIVES: Erectile dysfunction (ED) following trauma is challenging as traditional therapies are often ineffective. Low-energy shockwave therapy (LESWT) has shown promise in recovery of erectile function. This study aimed to determine whether the combination of phosphodiesterase-5 inhibitors (PDE5i) and LESWT would result in improved erectile function after pelvic crush injury.
METHODS: 30 Lewis rats, aged 10-12 weeks, were divided into five groups: sham operation, bilateral cavernous nerve crush injury and bilateral internal pudendal bundle ligation without treatment (control), injury with PDE5i, injury with LESWT, and injury with LESWT and PDE5i (n¼6 rats/group). Forty-eight hours after injury groups were started on three times weekly LESWT (1000 pulses at 0.06 mJ/mm2 and 3Hz) or sildenafil was given by mouth mixed into daily drinking water at 5-20 mg/kg/day (water intake ad libitum) with a 1% sucrose additive, for four weeks. Following a one week washout period (week 5), final intracavernous pressure (ICP) was then taken at week 6 as the final outcome measure.
RESULTS: Pelvic neurovascular injury resulted in a significant decrease in erectile function as measured by maximum ICP, average ICP and change in ICP (p¼0.003, 0.001, 0.007, respectively). Erectile function was recovered completely with combination PDE5i and LESWT as measured by maximum ICP, average ICP, and change in ICP (when compared to the sham group p¼0.636, 0.184, 0.5; control group p¼0.0006, 0.0001, 0.0002). LESWT alone was seen to have partial recovery as measured by maximum ICP (compared to sham p¼0.066) and change in ICP (versus control p¼0.05, versus sham p¼0.2). PDE5i alone was not shown to have significant erectile recovery.
CONCLUSIONS: Combination therapy with sildenafil and LESWT resulted in complete recovery of erectile function in a rat model of pelvic nerve injury. Combination therapy was superior to individual therapy alone. Vol. 199, No. 4S, Supplement, Saturday, May 19, 2018 THE JOURNAL OF UROLOGY â e579
Source of Funding: None
MP43-02 SERUM CADMIUM LEVELS PREDICT ERECTILE DYSFUNCTION IN MEN
Joseph Gabrielsen*, Larry Lipshultz, Dolores Lamb, Houston, TX
INTRODUCTION AND OBJECTIVES:
Cadmium is a naturally occurring heavy metal. Low-level exposure to cadmium is common in humans and occurs predominantly through smoking and ingestion of foods contaminated by bioaccumulation. In the human body, cadmium behaves similar to zinc and is widely distributed; however, unlike zinc, it is a known neurotoxin. Injections of high concentrations of cadmium induce erectile dysfunction in rats. Nonetheless, the effects of cadmium exposure-and particularly low-level cadmium exposure-on erectile function in humans remains unknown. We therefore tested the hypothesis that serum cadmium levels were predictive of erectile dysfunction in the general population.
METHODS: 2086 adult men who completed the erectile function question of the Prostate Conditions Questionnaire in the National Health and Nutrition Examination Survey (NHANES 2001 (NHANES -2002 were included in the study. Erectile function was reported on an ordinal scale with 1 representing "Always or almost always" and 4 representing "Never" able to get and keep an erection. Serum cadmium levels were measured using an atomic absorption spectrometer with a lower limit of detection of 0.2 mg/L. Univariate ordinal logistic regression was performed to determine an association between erectile function and serum cadmium levels. Multivariate ordinal logistic regression was then performed to control for BMI, age, ethnicity and self-reported smoking and diabetes status. Men with missing data points were excluded from the multivariate analysis (n¼79).
RESULTS: Serum cadmium levels were above the lower limit of detection in 68% (1426/2086) participants. Self-reported erectile function was negatively associated with serum cadmium levels (p¼0.003). In the multivariate analysis, serum cadmium level remained an independent predictor of erectile function after adjustment for BMI, age, ethnicity and self-reported smoking and diabetes status (p¼0.006). When the upper limit of normal for cadmium was set to 0.4 mg/L (95% upper limit of the normal range for non-smoking adults), men with elevated cadmium levels were more likely to report erectile dysfunction than those with normal levels (OR 1.65, 95% CI 1.39-1.98).
CONCLUSIONS: Serum cadmium levels are independently predictive of erectile dysfunction in men in the general population. As smoking is the main source of cadmium exposure in the United States, these data provide additional evidence for the deleterious effects of smoking on erectile function. 
MP43-03 3T FUNCTIONAL MRI DETECTS DIFFERENCES IN NEURAL ACTIVATION AMONG MEN WITH DELAYED EJACULATION & ORGASM
Ryan Flannigan*, Linda Heier, Henning Voss, Levi Chazen, Darius Paduch, New York, NY INTRODUCTION AND OBJECTIVES: Mechanisms underlying DO are poorly understood; however, the associations to centrally acting medications provide a strong rationale for aberrant neural signaling. Neuroimaging studies have characterized normal sexual function but little data exists among pathologic conditions such as DO. The objective of this study is to use neuroimaging techniques to investigate differential neural signaling among men with DO.
METHODS: 4 subjects with a history of DO and 6 controls with normal time to ejaculation were included in this study. Subjects completed an international index of erectile function (IIEF), and male sexual health (MSHQ) questionnaires. Subjects underwent a 3 Tesla functional magnetic resonance imaging (fMRI) study while viewing 3 video conditions: a neutral control (NC), positive emotional control (EC), and a sexual condition (SC). Each condition was repeated 5 times, using unique 50 second clips in a pseudorandomized fashion. fMRI data was analyzed using SPM12 software in a block-design. Areas of differential activation were then evaluated using the Allen Brain Atlas microarray pipeline.
RESULTS: Among the 10 subjects, differential activation in the sexual video condition compared to NC and ECs revealed increased activation in the right frontal inferior operculum (p¼0.008), and mid occipital gyrus (p¼0.002). These regions have demonstrated activation during previous studies in response to both visual sexual stimuli and tactile stimulation. Between group differences identified increased activation in the right frontal inferior operculum (p¼0.001) among the 4 men with DO compared to the 6 controls. Using the Allen Brain Atlas microarray pipeline, we identified corresponding neurotransmitter receptors to this region: adenosine, muscarinic and nicotinic cholinergic receptors, cannabinoid, dopamine, GABA A and B, ionotropic and metabotropic glutamate receptors, histamine, serotonin, and thyrotropin-releasing hormone receptors.
CONCLUSIONS: Using a 3T fMRI, this study was able to detect differences in neural activation upon visualizing sexual stimuli among men with a history of DO compared to controls. These regions are rich in numerous neurotransmitter receptor subtypes, and may be amenable to pharmacologic targeting to identify novel therapies for these men. INTRODUCTION AND OBJECTIVES: Seventy-two percent of prostatectomy patients develop stress urinary incontinence (SUI) in the first week after surgery, and individuals who do not recover within 6 months, generally do no regain function without intervention (44%). Preoperative erectile function predicts post-prostatectomy continence and SUI recovery correlates with neurovascular bundle sparing, suggesting the importance of maintaining neural innervation. The hypogastric (HYG) and pelvic nerves (PN) control bladder neck and bladder contraction/relaxation. We hypothesize that the HYG and PN may be injured during prostatectomy, in a similar manner to cavernous nerve (CN) injury, and thus contribute to post-prostatectomy SUI development. We will examine HYG, PN and CN architecture and signaling in normal pelvic ganglia and in a rat prostatectomy model. METHODS: The pelvic plexus in normal (n¼9), sham (n¼8) and CN crushed (n¼20) adult Sprague Dawley rats was examined for apoptotic index and sonic hedgehog (SHH) pathway signaling by
